Tema: Re: Del poregistraciniu studiju
Autorius: CatBlack
Data: 2010-02-25 16:20:46
Tikriausiai:)
"sooriz" <nera@mailo.lt> wrote in message 
news:hm5ut2$sfo$1@trimpas.omnitel.net...
O Cervarix irgi ta pacia indikacija paims? :)

"ArunasM" <aaa@ssss.com> wrote in message
news:hm49u5$89v$1@trimpas.omnitel.net...
> nujo.. ilgai reikejo mastyt...
> http://www.merck.com/newsroom/news-release-archive/product/2010_0217.html
>
>
>
>
> "CatBlack" <darius@asotra_no.spam.lt> wrote in message
> news:hm3u91$tq0$1@trimpas.omnitel.net...
>> Nu taigis zinome, zinome:)
>>
>> "ArunasM" <aaa@ssss.com> wrote in message
>> news:hm3omp$nrv$1@trimpas.omnitel.net...
>>> prekiaukit prekiaukit :)
>>>
>>> P.S.
>>> Gardasil = Silgard
>>>
>>>
>>> "CatBlack" <darius@asotra_nospam.lt> wrote in message
>>> news:hm2t70$e5j$1@trimpas.omnitel.net...
>>>> Studijos is tikruju vyksta - itraukiama vis daugiau potencialiu
>>>> "vartotoju":
>>>>
>>>> "Merck & Co. announced Wednesday that results from two studies suggest
>>>> that
>>>> the company's human papillomavirus (HPV) vaccine Gardasil protected
>>>> women
>>>> aged 24 to 45 years from developing cervical cancer and homosexual men
>>>> from
>>>> developing anal cancer.Merck & Co. announced Wednesday that results
>>>> from two
>>>> studies suggest that the company's human papillomavirus (HPV) vaccine
>>>> Gardasil protected women aged 24 to 45 years from developing cervical
>>>> cancer
>>>> and homosexual men from developing anal cancer."
>>>>
>>>>
>>>
>>>
>>
>>
>
>